l General Information |
Product Name | Cefpiramide sodium |
General description | Cefpiramide sodium (CPMS) is an anionic β-lactam antibiotic. It exhibits antibacterial activity against gram-positive and gram-negative bacteria, in particular, to Pseudomonas aeruginosa, which can result in achronic life-threatening infection in the lungs of cystic fibrosis patients. |
Synonym | SM-1652, wy-44635 |
Purity | ≥95.0%(HPLC) | CAS Number | 74849-93-7 |
Formula | C25H23N8NaO7S2 | Molecular Weight | 634.61929 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | Insoluble |
Water | ≥50mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Cefpiramide Sodium is the sodium salt form of cefpiramide, a third-generation, semi-synthetic, beta-lactam cephalosporin antibiotic with antibacterial activity. Cefpiramide binds to penicillin-binding proteins (PBPs), transpeptidases that are responsible for crossing of peptidoglycan. By preventing crossing of peptidoglycan, cell wall integrity is lost and cell wall synthesis is halted. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
